Takeda and SGC Announce a Collaboration Agreement Using Patient TissueBased Assays for Clinical Target Validation in Inflammatory Bowel Disease

Takeda Pharmaceutical Company Limited Takeda TSE 4502 Karolinska Institutet KI and The Structural Genomics Consortium SGC today announced a combined precompetitive and proprietary collaboration to discover and validate new potential...